BRIEF published on 10/23/2026 at 18:05, 9 days 2 hours ago ABIVAX: Statement of share capital and voting rights as of September 30, 2026 Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF published on 09/30/2026 at 22:10, 1 month ago Abivax presents obefazimod at UEG Week 2026 Abivax Obefazimod Ulcerative Colitis Clinical Data UEG Week
BRIEF published on 09/30/2026 at 22:10, 1 month ago Abivax to Showcase Obefazimod Data at UEG Week 2026 Abivax Obefazimod Ulcerative Colitis Clinical Trials UEG Week 2026
PRESS RELEASE published on 09/30/2026 at 22:05, 1 month ago Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026 Abivax to present data on Obefazimod at United European Gastroenterology Week 2026 covering Phase 3 ABTECT trials, Phase 2 findings, and preclinical research Abivax Obefazimod Phase 3 Trials Inflammatory Bowel Disease United European Gastroenterology
BRIEF published on 09/25/2026 at 18:05, 1 month 6 days ago ABIVAX: Information on share capital and voting rights as of August 31, 2026 Euronext Paris Share Capital Voting Rights Abivax Financial Markets
BRIEF published on 09/25/2026 at 11:41, 1 month 6 days ago BlackRock crosses thresholds in ABIVAX's capital Voting Rights Abivax BlackRock Crossing Thresholds Transfer Of Shares
BRIEF published on 09/22/2026 at 10:43, 1 month 9 days ago BlackRock exceeds 5% of ABIVAX's capital Euronext Paris Abivax BlackRock Threshold Crossing Capital And Voting Rights
BRIEF published on 09/21/2026 at 22:10, 1 month 9 days ago Abivax Reports Business Updates and First Half 2026 Financial Results Financial Results Biotechnology Leadership Changes Abivax Obefazimod
BRIEF published on 09/21/2026 at 22:10, 1 month 9 days ago Abivax strengthens its team and announces its financial results for H1 2026 Financial Results Abivax Appointment R&D Marketing
PRESS RELEASE published on 09/21/2026 at 22:05, 1 month 9 days ago Abivax Presents Business Updates and First Half 2026 Financial Results Abivax presents business updates and first half 2026 financial results, including leadership team changes and financial highlights Financial Results Abivax Leadership Team Commercialization Business Updates
Published on 10/30/2026 at 23:35, 1 day 20 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 20 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 1 hour ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 4 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 9 hours 53 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 15 hours 28 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 3 hours ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 21 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 21 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 2 days 8 hours ago Capital increase through exercise of subscription rights
